# Transplantation Efficacy of Autologous Bone Marrow Mesenchymal Stem Cells With Intensive Atorvastatin in AMI Patients

Study · id `cardio:ct-nct03047772` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03047772](<https://clinicaltrials.gov/study/NCT03047772>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03047772

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 124 participants.

## Technical summary

Registry record NCT03047772. Randomized; triple masking; primary purpose treatment. Start 2018-03-06 (anticipated); primary completion 2018-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 124 participants (planned count; ClinicalTrials.gov record NCT03047772, source copy `cardio:ctgov-nct03047772-2018-01-25`, retrieved 2026-10-26)
- Planned start: 2018-03-06 (anticipated) (ClinicalTrials.gov record NCT03047772, source copy `cardio:ctgov-nct03047772-2018-01-25`, retrieved 2026-10-26)
- Primary completion: 2018-12-31 (anticipated) (ClinicalTrials.gov record NCT03047772, source copy `cardio:ctgov-nct03047772-2018-01-25`, retrieved 2026-10-26)
- Completion: 2018-12-31 (anticipated) (ClinicalTrials.gov record NCT03047772, source copy `cardio:ctgov-nct03047772-2018-01-25`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03047772-2018-01-25`, retrieved 2026-10-26)

## The registry's words

- Brief title: Transplantation Efficacy of Autologous Bone Marrow Mesenchymal Stem Cells With Intensive Atorvastatin in AMI Patients
- Acronym: TEAM-AMI
- Condition: Myocardial Infarction
- Condition: Stem Cell Transplantation
- Condition: Angioplasty, Transluminal, Percutaneous Coronary
- Intervention (Drug): Atorvastatin
- Intervention (Drug): Intensive Atorvastatin
- Intervention (Drug): Low dose BMMSC
- Intervention (Drug): Middle dose BMMSC
- Intervention (Drug): High dose BMMSC
- Intervention (Drug): Transplantation
- Lead sponsor: Yuejin Yang
- Lead sponsor class: OTHER
- Collaborator: Peking Union Medical College Hospital
- Collaborator class: OTHER
- Collaborator: The First Hospital of Hebei Medical University
- Collaborator class: OTHER
- Collaborator: Zunyi Medical College
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry intervention name matches this record: Atorvastatin (`cardio:atorvastatin`)
- Registry lists this organization as a collaborator: Peking Union Medical College Hospital (`cardio:org-peking-union-medical-college-hospital`)
- Registry lists this organization as a collaborator: The First Hospital of Hebei Medical University (`cardio:org-the-first-hospital-of-hebei-medical-university`)
- Registry lists this organization as a collaborator: Zunyi Medical College (`cardio:org-zunyi-medical-college`)

## Provenance

Content hash: df635b02a4b0dc50dd402a750c946b07edffc28698cecd5159ed13a5a3260d33
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
